“FORMULATION, OPTIMIZATION AND EVAULATION OF …

The pKa is 2.27 and 9.25, half life 2-3 hours; protein binding 9-33%, melting point is 256.50C7. The present investigation is focused to develop bioadhesive vaginal tablets of acyclovir that is designed to prolong the residence time and consequently to obtain a long therapeutic concentration at … ................
................